Results 291 to 300 of about 1,464,129 (347)

Tumour–host interactions in Drosophila: mechanisms in the tumour micro‐ and macroenvironment

Molecular Oncology, EarlyView.
This review examines how tumour–host crosstalk takes place at multiple levels of biological organisation, from local cell competition and immune crosstalk to organism‐wide metabolic and physiological collapse. Here, we integrate findings from Drosophila melanogaster studies that reveal conserved mechanisms through which tumours hijack host systems to ...
José Teles‐Reis, Tor Erik Rusten
wiley   +1 more source

2024 American Society of Clinical Oncology Genitourinary (ASCO-GU) Cancers Symposium Meeting highlights. [PDF]

Can Urol Assoc J
Graham J, Fallah-Rad N, Kolinsky M, Morgan S, Shayegan B.   +4 more
europepmc   +1 more source

Facilitators and barriers to implementing patient-reported outcomes in clinical oncology practice: a systematic review based on the consolidated framework for implementation research. [PDF]

Implement Sci Commun
Lyu J, Zhang H, Wang H, Liu X, Jing Y, Yin L, Wang A.   +6 more
europepmc   +1 more source

Biomarker Testing and Patterns of Treatment in Patients with NSCLC: An International Association for The Study of Lung Cancer Analysis of American Society of Clinical Oncology CancerLinQ Discovery Data. [PDF]

JTO Clin Res Rep
Behera M, Joseph G, Rupji M, Huang Z, Bunn B, Wynes MW, Switchenko J, Scagliotti GV, Tsao MS, Belani CP, Sequist LV, Ramalingam SS.   +11 more
europepmc   +1 more source

Implementation of the REFLECT Communication Curriculum for Clinical Oncology Graduate Medical Education. [PDF]

J Palliat Med
Vern-Gross TZ, Laughlin BS, Kough K, Ernst B, Langley N, Rule WG, Patel SH, Ashman JB.   +7 more
europepmc   +1 more source

Cost of medical care for malignant brain tumors at hospitals in the Japan Clinical Oncology Group brain-tumor study group. [PDF]

Jpn J Clin Oncol
Motomura K, Sasaki K, Sugii N, Yamaguchi S, Inoue H, Oshima A, Tanaka K, Otani Y, Shirahata M, Shibahara I, Nagane M, Tsuzuki S, Matsutani T, Tsukamoto Y, Kijima N, Asano K, Ohno M, Inoue A, Mineharu Y, Miyake K, Mitobe Y, Hanihara M, Kawanishi Y, Deguchi S, Saito M, Matsuda R, Ujifuku K, Arita H, Sato Y, Yamashita S, Yonezawa U, Yamaguchi J, Momii Y, Ogawa T, Kambe A, Ohba S, Fukai J, Saito N, Kinoshita M, Sumi K, Otani R, Uzuka T, Takebe N, Koizumi S, Saito R, Arakawa Y, Narita Y, Members of Japan Clinical Oncology Group Brain Tumor Study Group (JCOG-BTSG).   +47 more
europepmc   +1 more source

Integrating accompanying patients into clinical oncology teams: limiting and facilitating factors. [PDF]

BMC Health Serv Res
Pomey MP, Paquette J, Nelea MI, Vialaron C, Mourad R, Bouchard K, Normandin L, Côté MA, Desforges M, Pomey-Carpentier P, Fortin I, Ganache I, Régis C, Rosberger Z, Charpentier D, Vachon MF, Bélanger L, Dorval M, Ghadiri DP, Lavoie-Tremblay M, Boivin A, Pelletier JF, Fernandez N, Danino AM, de Guise M.   +24 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Oncology clinical trials

The Case Manager, 1999
In 1971, President Nixon declared a "war on cancer" and initiated substantial funding for the National Cancer Program, which has been sustained through the years with a significant return on investment. Recently released 1998 statistics from the National Cancer Institute (NCI), the Centers for Disease Control and Prevention, and the American Cancer ...
P, Mellody, A, Dehgan
openaire   +2 more sources

Hemopoietins in Clinical Oncology

American Journal of Clinical Oncology, 1991
Despite major advances in supportive care, neutropenic infections and thrombopenic bleedings remain major lethal treatment- and disease-related complications in patients with malignancy. Moreover, complications of platelet (Plt) and erythrocyte transfusion therapy have become a cause of great concern and shortages of homologous blood products are a ...
L, Kanz, A, Lindemann, W, Oster, F, Herrmann, R, Mertelsmann   +4 more
openaire   +2 more sources

Women and clinical oncology

Clinical Oncology, 1993
In the United Kingdom 20% of consultants and 23% of senior registrars are female. A questionnaire sent to female clinical oncologists revealed that 90% have full-time contracts, although 36% had spent time in part-time training. Sixty-seven per cent of the total have children and the husbands of 51% of the 74% who are married are doctors.
E, Junor, J, Barrett
openaire   +2 more sources